Lifeward Ltd. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability

Reuters
05/22
<a href="https://laohu8.com/S/LFWD">Lifeward Ltd</a>. Unveils Investor Presentation Showcasing Innovative Rehabilitation Technologies and Path to Profitability

Lifeward Ltd., formerly known as ReWalk Robotics, has unveiled its latest investor presentation, highlighting its innovative technologies aimed at transforming the lives of individuals with physical limitations or disabilities. The company has made significant strides with its ReWalk Personal Exoskeleton, which has received both FDA and CE approvals, and the AlterG Anti-Gravity Systems, utilizing NASA-derived Differential Air Pressure technology. Lifeward Ltd. is also expanding its market presence, particularly in the U.S. and Germany, with Medicare coverage in place since April 2024. The company is focusing on securing private insurance coverage to further grow its addressable market. Lifeward Ltd. is on a path to profitability, expecting to reduce operating losses in 2025 and achieve profitability by 2026. The full presentation can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief on May 22, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10